Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Medical Brick is a German health-tech and biotech startup focused on applying artificial intelligence to microscopic image analysis, high-content phenotypic screening, and drug discovery. The company appears to position itself as a platform business rather than a single-asset therapeutic developer, using deep learning to support both diagnostic workflows and biomedical/pharmaceutical screening. Publicly available descriptions emphasize accelerated discovery of new drug candidates and automated detection of infections and pathogens. The company is early stage, with no clearly disclosed named clinical pipeline or later-stage development assets identified in public sources.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Medical Brick.